Works matching IS 01495992 AND DT 2004 AND VI 27 AND IP 8


Results: 69
    1
    2
    3

    Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition.

    Published in:
    2004
    By:
    • Klein S;
    • Sheard NF;
    • Pi-Sunyer X;
    • Daly A;
    • Wylie-Rosett J;
    • Kulkarni K;
    • Clark NG;
    • Klein, Samuel;
    • Sheard, Nancy F;
    • Pi-Sunyer, Xavier;
    • Daly, Anne;
    • Wylie-Rosett, Judith;
    • Kulkarni, Karmeen;
    • Clark, Nathaniel G;
    • American Diabetes Association;
    • North American Association for the Study of Obesity;
    • American Society for Clinical Nutrition
    Publication type:
    journal article
    4
    5

    Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study.

    Published in:
    2004
    By:
    • Wackers FJT;
    • Young LH;
    • Inzucchi SE;
    • Chyun DA;
    • Davey JA;
    • Barrett EJ;
    • Taillefer R;
    • Wittlin SD;
    • Heller GV;
    • Filipchuk N;
    • Engel S;
    • Ratner RE;
    • Iskandrian AE;
    • Detection of Ischemia in Asymptomatic Diabetics (DIAD) Investigators;
    • Wackers, Frans J Th;
    • Young, Lawrence H;
    • Inzucchi, Silvio E;
    • Chyun, Deborah A;
    • Davey, Janice A;
    • Barrett, Eugene J
    Publication type:
    journal article
    6
    7
    8
    9
    10
    11
    12

    Issues and Updates.

    Published in:
    Diabetes Care, 2004, v. 27, n. 8, p. 2100
    Publication type:
    Article
    13

    Erratum.

    Published in:
    2004
    Publication type:
    Correction Notice
    15
    17
    18
    19
    21
    22
    23
    24

    Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in patients with type 2 diabetes, hypertension, and renal disease.

    Published in:
    2004
    By:
    • Palmer, Andrew J.;
    • Annemans, Lieven;
    • Roze, Stiéphane;
    • Lamotte, Mark;
    • Lapuerta, Pablo;
    • Chen, Roland;
    • Gabriel, Sylvie;
    • Carita, Paulo;
    • Rodby, Roger A.;
    • Zeeuw, Dick De;
    • Parving, Hans-Henrik;
    • Roze, Stéphane;
    • de Zeeuw, Dick
    Publication type:
    journal article
    25
    27
    28
    29
    30
    31
    32
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Inflammation, Insulin Resistance, and Adiposity.

    Published in:
    Diabetes Care, 2004, v. 27, n. 8, p. 2033, doi. 10.2337/diacare.27.8.2033
    By:
    • Kriketos, Adamandia D.;
    • Greenfield, Jerry R.;
    • Peake, Phil W.;
    • Furler, Stuart M.;
    • Denyer, Gareth S.;
    • Charlesworth, John A.;
    • Campbell, Lesley V.
    Publication type:
    Article
    46
    47
    48
    49
    50